Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

计划入组 100 人 · 首次发布于 2025 年 12 月 17 日

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

计划入组 24 人 · 首次发布于 2008 年 9 月 19 日

NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

计划入组 215 人 · 首次发布于 2025 年 6 月 12 日

PIN1(Larkspur Biosciences)

TRPV4(actio biosciences)

Homocystinuria(Tome Biosciences)

Assembly Biosciences

United States

EUROMI BIOSCIENCES

France

Sagimet Biosciences

United States

QIAGEN Expands Molecular Biology Portfolio with SABiosciences Acquisition

Tyra Biosciences Advances FGFR Inhibitor Pipeline with Multiple Clinical Trials

FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer